Fabrication of cisplatin-loaded poly(lactide-co-glycolide) composite microspheres for osteosarcoma treatment

Pharmaceutical Research

Volumn 29, Issue 3, 2012, Pages 756-769

  Li, Yan ^a   Lim, Sierin ^a   Ooi, Chui Ping ^b  

^a Nanyang Technological University   (Singapore)

^b SINGAPORE UNIVERSITY OF SOCIAL SCIENCES   (Singapore)

Author keywords

Cisplatin; Drug release; Hydroxyapatite; Microspheres; Poly(lactide co glycolide)

Indexed keywords

CISPLATIN; FERRIC ION HYDROXYAPATITE NANOPARTICLE; HYALURONIC ACID; MICROSPHERE; NANOCARRIER; NANOPARTICLE; POLYGLACTIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FERRIC ION; HYDROXYAPATITE;

ARTICLE; CHEMICAL PARAMETERS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG LOADING; EMULSION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; GLASS TRANSITION TEMPERATURE; MOLECULAR WEIGHT; NANOENCAPSULATION; NANOFABRICATION; OIL IN WATER SINGLE EMULSION; OSTEOSARCOMA; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HUMAN;

ANTINEOPLASTIC AGENTS; CISPLATIN; DELAYED-ACTION PREPARATIONS; DURAPATITE; FERRIC COMPOUNDS; HUMANS; MICROSPHERES; OSTEOSARCOMA; POLYGLACTIN 910;

EID: 84862311139     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0600-9     Document Type: Article

References (47)

1. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev. 2006;32:423-36.
2. Yanand X, Gemeinhart RA. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. J Control Release. 2005;106:198-208.
3. Cvitkovic E. Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev. 1998;24:265-81.
4. van Leeuwen BL, Kamps WA, Jansen HWB, Hoekstra HJ. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev. 2000;26:363-76.
5. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79:123-35.
6. Jeong Y-I, Kim S-T, Jin S-G, Ryu H-H, Jin Y-H, Jung T-Y, et al. Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation. J Pharm Sci. 2008;97:1268-76.
7. Barroug A, Glimcher MJ. Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro. J Orthop Res. 2002;20:274-80.
8. Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ. Interactions of cisplatin with calcium phosphate nanoparticles: In vitro controlled adsorption and release. J Orthop Res. 2004;22:703-8.
9. Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi CL, et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater. 2007;17:2180-8.
10. Ike O, Shimizu Y, Wada R, Hyon SH, Ikada Y. Controlled cisplatin delivery system using poly(d, l-lactic acid). Biomaterials. 1992;13:230-4.
11. Fujiyama J, Nakase Y, Osaki K, Sakakura C, Yamagishi H, Hagiwara A. Cisplatin incorporated in microspheres: development and fundamental studies for its clinical application. J Control Release. 2003;89:397-408.
12. Matsumoto A, Matsukawa Y, Horikiri Y, Suzuki T. Rupture and drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co- glycolide) and poly(dl-lactide). Int J Pharm. 2006;327:110-6.
13. Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H. Drug release characteristics of multi-reservoir type microspheres with poly(dllactide-co- glycolide) and poly(dl-lactide). J Control Release. 2005;106:172-80.
14. Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H, Kobayashi M. The polymer-alloys method as a new preparation method of biodegradable microspheres: principle and application to cisplatin-loaded microspheres. J Control Release. 1997;48:19-27.
15. Itoi K, Tabata CY, Ike O, Shimizu Y, Kuwabara M, Kyo M, et al. In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cells. J Control Release. 1996;42:175-84.
16. Huo D, Deng S, Li L, Ji J. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm. 2005;289:63-7.
17. Moreno D, de Ilarduya CT, Bandre E, Bunuales M, Azcona M, Garcia-Foncillas J, et al. Characterization of cisplatin cytotoxicity delivered from PLGA-systems. Eur J Pharm Biopharm. 2008;68:503-12.
18. Nishiyama N, Kataoka K. Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J Control Release. 2001;74:83-94.
19. Schroeder A, Honen R, Turjeman K, Gabizon A, Kost J, Barenholz Y. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release. 2009;137:63-8.
20. Keskar V, Mohanty PS, Gemeinhart EJ, Gemeinhart RA. Cervical cancer treatment with a locally insertable controlled release delivery system. J Control Release. 2006;115:280-8.
21. Terwogt JMM, Schellens JHM, Huinink WWtB, Beijnen JH. Clinical pharmacology of anticancer agents in relation to formulations and administration routes. Cancer Treat Rev. 1999;25:83-101.
22. Li Y, Widodo J, Lim S and Ooi CP. Synthesis and cytocompatibility of manganese(II) and iron(III) substituted hydroxyapatite nanoparticles. J Mater Sci, 2011, doi:10.1007/s10853-011-5851-7.
23. Li H, Chang J. pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA. Compos Sci Technol. 2005;65:2226-32.
24. Agrawal CM, Kyriacos AA. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J Biomed Mater Res. 1997;38:105-14.
25. Martin C, Winet H, Bao JY. Acidity near eroding polylactide-polyglycolide in vitro and in vivo in rabbit tibial bone chambers. Biomaterials. 1996;17:2373-80.
26. Linhart W, Peters F, Lehmann W, Schwarz K, Schilling AF, Amling M, et al. Biologically and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials. J Biomed Mater Res. 2001;54:162-71.
27. Chen X, Ooi CP. Hydrolytic degradation and drug release properties of ganciclovir-loaded biodegradable microspheres. Acta Biomater. 2008;4:1046-56.
28. Amado AM, Fiuza SM, Marques MPM, Batista de Carvalho LAE. Conformational and vibrational study of platinum(II) anticancer drugs: cis- diamminedichloroplatinum (II) as a case study. J Chem Phys. 2007;127:185104.
29. Chen X, Ooi CP, Lye WS, Lim TH. Sustained release of ganciclovir from poly(lactide-co-glycolide) microspheres. J Microencapsul. 2005;22:621-31.
30. Park TG. Degradation of poly(D, L-lactic acid) microspheres: effect of molecular weight. J Control Release. 1994;30:161-73.
31. Rouse JJ, Mohamed F, van der Walle CF. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm. 2007;339:112-20.
32. Yoshioka T, Kawazoe N, Tateishi T, Chen G. In vitro evaluation of biodegradation of poly(lactic-co-glycolic acid) sponges. Biomaterials. 2008;29:3438-43.
33. Giunchedi P, Conti B, Scalia S, Conte U. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. J Control Release. 1998;56:53-62
34. Yung W-KA, Shapiro JR, Shapiro WR. Heterogeneous chemo-ensitivities of subpopulations of human glioma cells in culture. Cancer Res. 1982;42:992-8.
35. Lippard SJ. New chemistry of an old molecules: cis-[Pt(NH3)2Cl2]. Science. 1982;218:1075-82.
36. Yotsuyanagi T, Usami M, Noda Y, Nagata M. Computational consideration of cisplatin hydrolysis and acid disociation in aqueous media: effect of total drug concentrations. Int J Pharm. 2002;246:95-104.
37. Sheindorf C, Rebhun M, Sheintuch M. A Freundlich-type multicomponent isotherm. J Colloid Interface Sci. 1981;79:136-42.
38. Urano K, Koichi Y, Nakazawa Y. Equilibria for adsorption of organic compounds on activated carbons in aqueous solutions I. Modified Freundlich isotherm equation and adsorption potentials of organic compounds. J Colloid Interface Sci. 1981;81:477-85.
39. Chval Z, Sip M. Pentacoordinated transition states of cisplatin hydrolysis-ab initio study. J Mol Struct. 2000;532:59-68.
40. Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release. 2004;99:271-80.
41. Nagata F, Miyajima T, Yokogawa Y. Surfactant-free preparation of poly (lactic acid)/hydroxyapatite microspheres. Chem Lett. 2003;32:784-5.
42. Siepmann J, Elkharraz K, Siepmann F, Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules. 2005;6:2312-9.
43. Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm. 2006;314:198-206.
44. Miyajima M, Koshika A, Okada Ji, Ikeda M. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix. J Control Release. 1999;61:295-304.
45. Bontha S, Kabanov AV, Bronich TK. Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J Control Release. 2006;114:163-74.
46. Ye H, Jin L, Hu R, Yi Z, Li J, Wu Y, et al. Poly (γ, L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials. 2006;27:5958-65.
47. Bouissou C, Rouse JJ, Price R, Walle CFvd. The influence of surfactant on PLGA microsphere glass transition and water sorption: remodeling the surface morphology to attenuate the burst release. Pharm Res. 2006;23:1295-305.